You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 5, May 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Schizophrenia
 •Magnetic Resonance Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Progressive and Interrelated Functional and Structural Evidence of Post-Onset Brain Reduction in Schizophrenia

Dean F. Salisbury, PhD; Noriomi Kuroki, MD, PhD; Kiyoto Kasai, MD, PhD; Martha E. Shenton, PhD; Robert W. McCarley, MD

Arch Gen Psychiatry. 2007;64(5):521-529.

Context  Progressive brain abnormalities in schizophrenia remain controversial. Evidence of interrelated progressive functional impairment would buttress the case for structural progression. Mismatch negativity (MMN) is reduced in chronic but not first-hospitalized schizophrenia and may index progressive structural changes.

Objective  To determine whether MMN shows associations with underlying auditory cortex gray matter at first hospitalization and progressive reduction longitudinally.

Design  Cross-sectional (first hospitalization) and longitudinal (1.5-year follow-up).

Setting  A private psychiatric hospital.

Participants  Protocol entrance: MMN and magnetic resonance imaging at first hospitalization in 20 subjects with schizophrenia, 21 subjects with bipolar disorder with psychosis, and 32 control subjects. Longitudinal electrophysiologic testing: MMN in 16 subjects with schizophrenia, 17 subjects with bipolar disorder, and 20 control subjects. Longitudinal electrophysiologic testing and magnetic resonance imaging: MMN and magnetic resonance imaging in 11 subjects with schizophrenia, 13 subjects with bipolar disorder, and 13 control subjects. At each time point, reported samples were group matched for age, handedness, and parental socioeconomic status.

Interventions  Electrophysiologic testing and high-resolution structural magnetic resonance imaging.

Main Outcome Measures  Mismatch negativity amplitude and Heschl gyrus and planum temporale gray matter volumes.

Results  Initially, groups did not differ in MMN amplitude. Subjects with schizophrenia showed associations between MMN and Heschl gyrus (r = –0.52; P = .02) not present in the other groups. At longitudinal MMN testing, schizophrenia showed MMN reduction (P = .004). Only schizophrenia evinced longitudinal left hemisphere Heschl gyrus reduction (P = .003), highly correlated with MMN reduction (r = 0.6; P = .04).

Conclusions  At first hospitalization for schizophrenia, MMN indexed left hemisphere Heschl gyrus gray matter volume, consistent with variable progression of prehospitalization cortical reduction. Longitudinally, the interrelated progressive reduction of functional and structural measures suggests progressive pathologic processes early in schizophrenia. An active process of progressive cortical reduction presents a potential therapeutic target. Mismatch negativity may be a simple, sensitive, and inexpensive index not only of this progressive pathologic process but also of successful intervention.


Author Affiliations: Veterans Affairs Boston Healthcare System, Brockton Division, Brockton (Drs Salisbury, Kuroki, Kasai, Shenton, and McCarley); Department of Psychiatry, Harvard Medical School, Boston (Drs Salisbury, Kuroki, Kasai, Shenton, and McCarley); Cognitive Neuroscience Laboratory, McLean Hospital, Belmont (Drs Salisbury, Shenton, and McCarley); and Surgical Planning Laboratory, Brigham and Women's Hospital, Boston (Drs Kuroki, Kasai, and Shenton), Mass. Drs Kuroki and Kasai are now with the Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gray Matter Deficits, Mismatch Negativity, and Outcomes in Schizophrenia
Rasser et al.
Schizophr Bull 2009;0:sbp060v1-sbp060.
ABSTRACT | FULL TEXT  

Progressive Gray Matter Reduction of the Superior Temporal Gyrus During Transition to Psychosis
Takahashi et al.
Arch Gen Psychiatry 2009;66:366-376.
ABSTRACT | FULL TEXT  

Why psychiatry can't afford to be neurophobic
Bullmore et al.
Br. J. Psychiatry 2009;194:293-295.
ABSTRACT | FULL TEXT  

Reductions in the N1 and P2 Auditory Event-Related Potentials in First-Hospitalized and Chronic Schizophrenia
Salisbury et al.
Schizophr Bull 2009;0:sbp003v1-sbp003.
ABSTRACT | FULL TEXT  

Auditory cortex asymmetry, altered minicolumn spacing and absence of ageing effects in schizophrenia
Chance et al.
Brain 2008;131:3178-3192.
ABSTRACT | FULL TEXT  

Getting the Cue: Sensory Contributions to Auditory Emotion Recognition Impairments in Schizophrenia
Leitman et al.
Schizophr Bull 2008;0:sbn115v2-sbn115.
ABSTRACT | FULL TEXT  

Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder
Kempton et al.
Arch Gen Psychiatry 2008;65:1017-1032.
ABSTRACT | FULL TEXT  

Progressive Brain Changes in Schizophrenia
Arango and Kahn
Schizophr Bull 2008;34:310-311.
FULL TEXT  

The Concept of Progressive Brain Change in Schizophrenia: Implications for Understanding Schizophrenia
DeLisi
Schizophr Bull 2008;34:312-321.
ABSTRACT | FULL TEXT  

What Happens After the First Episode? A Review of Progressive Brain Changes in Chronically Ill Patients With Schizophrenia
Hulshoff Pol and Kahn
Schizophr Bull 2008;34:354-366.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.